Parkinson's Disease Treatment through ProGenaCell Regenerative Medicine

ProGenaCell physicians have used clinically proven cell therapy to stimulate the regeneration of neuronal brain cells -- particularly in Parkinson's and autistic spectrum disorder patients -- at its affiliate clinics in Europe since 1998.

Parkinson's Disease

Conventional therapy is incapable of stimulating neuronal brain cell regeneration, rather relying on dopamine replacement therapy (L-DOPA or levodopa), which has undesirable effects and the limitation of not delaying the progression of dopaminergic neuronal loss for the life of the patient. When treatment with levodopa reaches its limits, some people opt for deep-brain stimulation (DBS) — electrodes are implanted in specific areas of the brain and act as a pacemaker for neural impulses, blocking signals that cause abnormal movement. Both levodopa and DBS can be effective for different stages of the disease, but neither is perfect and they both lose potency as the disease progresses.

What is ProGenaCell Regenerative Medicine ?

All organs in the body have specialized cells to perform a specific function, such as the liver, skin, or brain. Stem cells are relatively undifferentiated and still have the potency to develop into different types of cells to perform different functions. The most notable characteristic of a stem cell is its ability to reproduce a completely new, normal, and even younger cell. This permits the treatment of a wide range of diseases and injuries, many of which cannot be treated with traditional medical treatments.

In addition to reproducing new cells and providing cell replacement, an important function is to provide the body with renewed vigor in functions in the following area:

  • Immune regulation
  • Stimulate differentiation of the patient's stem cells
  • Promote neo-angiogenesis or the growth of blood vessels resulting in increased blood flow to damaged areas
  • Reduced scarring
  • Improving the effective conduction of intercellular electrical signals and transduction

It is clinically proven that Umbilical cord stem cells are effusive safe with minimal adverse effects in patients. No patients ever treated with ProGenaCell cells have developed serious adverse or Adverse Events due to treatment.

How Does ProGenaCell Regenerative Medicine Treat Parkinson's?

ProGenaCell physicians collate two distinct and separate cell-derived therapies into one powerful treatment therapy. When combined, these unitary therapies represent a highly effective regenerative treatment for Neurological Diseases.

The first protocol is the use of fresh cord blood cells. These cells come from human umbilical cord blood taken after an uneventful full-term birth. These young, potent cells have the capability of traveling to injured, diseased, and degenerative areas of the body and the crucial neuronal cells of the brain, powerfully bringing about healthy changes.

Parkinson's Disease

The second protocol uses select Growth Factors derived from organ-specific cells. These cells stimulate the cells within your own body to assist in their repair and regeneration. When your body is invaded by poisons, toxins, bacteria, and viruses the necessary Peptides or "Growth Factors" in an aging body may not be available in adequate quantities to heal damaged organs.

These treatments are administered without surgeries!

What is Parkinson's Disease?

Parkinson's disease is caused by brain inflammation, specifically by an intense activation of the brain's immune cells called "microglia." When over-activated, the microglia destroy parts of the mid-section of the brain, resulting in Parkinson's Disease.

The disease is mostly caused by infections, trauma, obesity, ingestion of certain harmful ingredients in processed foods (e.g. excessive carbohydrates), and exposure to toxic metals, pesticides, and herbicides.

Each brain cell is a tiny factory performing dozens of vital functions, including generating energy, making enzymes and proteins, storing information including DNA, and performing numerous mental tasks. Ideally, we want our brain cells to retain our memory, stay mentally sharp, and be capable of dealing with life daily.

Unfortunately, free radicals damage our cellular factories. So, over time, they do not work as well and eventually fail and die. Free radicals are highly reactive submicroscopic particles that bounce around inside your cells like red-hot BBs burning everything they touch.

Earlier in life, the damage is small and insignificant. However, over time, if the free radical activity goes unchecked, the cellular function becomes impaired. Fortunately, your body has antioxidant defenses when you are young to neutralize the free radicals. But antioxidant defenses decline with age. Moreover, if exposed to any of the triggers that cause inflammation or create more free radicals, the antioxidant defenses can be overwhelmed. Depending on your exposure to the triggers, this can occur at age 50, 60, 70, or 80.

What's most alarming is that what used to be common in the 70s and 80's age group is now showing up in the 50s and 60s, and sometimes as early as the 30s and 40s!

Prescribed medications used to treat degenerative neurological diseases do not control the symptoms indefinitely, which is why the dosage amounts must be increased continually. Ultimately, Parkinson's patients reach a point where the medications no longer stimulate the production of the neurotransmitter PD Medicine, as a result of select neurons of the patient's brain ceasing to function.

cellular therapy is the only path to stopping the progression of the disease and rebuilding the immune system.

Why do ProGenaCell therapies work for Parkinson's when other cellular companies have little or no results?

Start your treatment today!

Speak with a qualified ProGenaCell Representative today about the benefits of ProGenaCell Cell Therapy.

Thank you! Your message was sent successfully.

Oops! Something went wrong, please try again.

Working Time
  • Mon-Fri:    09:00 - 18:00
    Saturday:  09:00 - 14:00
    Sunday:     Closed
Follow Us
First of its kind Precision Tumor Targeted Immuno-Modulating Cancer Therapy!
Integrative Cancer Centers of America